These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17875672)

  • 1. Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model.
    Kota J; Machavaram KK; McLennan DN; Edwards GA; Porter CJ; Charman SA
    Drug Metab Dispos; 2007 Dec; 35(12):2211-7. PubMed ID: 17875672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep.
    McLennan DN; Porter CJ; Edwards GA; Heatherington AC; Martin SW; Charman SA
    Pharm Res; 2006 Sep; 23(9):2060-6. PubMed ID: 16951999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep.
    McLennan DN; Porter CJ; Edwards GA; Martin SW; Heatherington AC; Charman SA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheep.
    McLennan DN; Porter CJ; Edwards GA; Brumm M; Martin SW; Charman SA
    Pharm Res; 2003 Aug; 20(8):1156-62. PubMed ID: 12948012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats.
    Yoshioka E; Kato K; Shindo H; Mitsuoka C; Kitajima SI; Ogata H; Misaizu T
    Xenobiotica; 2007 Jan; 37(1):74-90. PubMed ID: 17178635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection.
    Charman SA; Segrave AM; Edwards GA; Porter CJ
    J Pharm Sci; 2000 Feb; 89(2):168-77. PubMed ID: 10688746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.
    Charman SA; McLennan DN; Edwards GA; Porter CJ
    Pharm Res; 2001 Nov; 18(11):1620-6. PubMed ID: 11758772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics, pharmacokinetics, and tolerability of intravenous or subcutaneous GC1113, a novel erythropoiesis-stimulating agent.
    Han H; Lee J; Shin D; Shin KH; Jeon H; Lim KS; Yoon SH; Shin SG; Jang IJ; Cho JY; Yu KS
    Clin Drug Investig; 2014 Jun; 34(6):373-82. PubMed ID: 24623104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic route of transport and pharmacokinetics of Micrurus fulvius (coral snake) venom in sheep.
    Paniagua D; Jiménez L; Romero C; Vergara I; Calderón A; Benard M; Bernas MJ; Rilo H; de Roodt A; D' Suze G; Witte MH; Boyer L; Alagón A
    Lymphology; 2012 Dec; 45(4):144-53. PubMed ID: 23700761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.
    Doshi S; Chow A; Pérez Ruixo JJ
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):75S-90S. PubMed ID: 20881221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivenom effect on lymphatic absorption and pharmacokinetics of coral snake venom using a large animal model.
    Paniagua D; Vergara I; Román R; Romero C; Benard-Valle M; Calderón A; Jiménez L; Bernas MJ; Witte MH; Boyer LV; Alagón A
    Clin Toxicol (Phila); 2019 Aug; 57(8):727-734. PubMed ID: 30773936
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats.
    Gao X; Voronin G; Generaux C; Rose A; Kozhich A; Dalglish G; Rosa R; Oh S; Kagan L
    Pharm Res; 2020 Jul; 37(8):155. PubMed ID: 32720159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of darbepoetin alfa after single, intravenous or subcutaneous administration in Japanese pediatric patients with chronic kidney disease.
    Uemura O; Hattori M; Hataya H; Ito S; Ito N; Akizawa T
    Clin Exp Nephrol; 2014 Dec; 18(6):932-8. PubMed ID: 24504705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of darbepoetin alpha in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration.
    Kawakami K; Takama H; Nakashima D; Tanaka H; Uchida E; Akizawa T
    Eur J Clin Pharmacol; 2009 Feb; 65(2):169-78. PubMed ID: 18807251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa.
    Pannier A; Jordan P; Dougherty FC; Bour F; Reigner B
    Curr Med Res Opin; 2007 Dec; 23(12):3025-32. PubMed ID: 17961301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic duct cannulation without thoracotomy in sheep: a method for accessing efferent lymph from the lung.
    Yen HH; Wee JL; Snibson KJ; Scheerlinck JP
    Vet Immunol Immunopathol; 2009 May; 129(1-2):76-81. PubMed ID: 19157567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model.
    Kagan L; Gershkovich P; Mendelman A; Amsili S; Ezov N; Hoffman A
    Eur J Pharm Biopharm; 2007 Nov; 67(3):759-65. PubMed ID: 17499981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation.
    Morkeberg J; Lundby C; Nissen-Lie G; Nielsen TK; Hemmersbach P; Damsgaard R
    Med Sci Sports Exerc; 2007 Oct; 39(10):1742-7. PubMed ID: 17909401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.